Collectively, together with the finding of higher synovial expression levels of HDAC1, these results suggest that overexpressing Smad7 to down-regulate the TGF-β signaling can be a beneficent approach in the RA therapy. This evidence concerns the gene SMAD7 and rheumatoid arthritis.